| J9271 | Injection, pembrolizumab, 1 mg | 10,000 | $40 | $430.1K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 3,240 | $40 | $123.3K |
| J9299 | Injection, nivolumab, 1 mg | 4,680 | $20 | $112.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $110 | $21.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 120 | $100 | $11.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $140 | $7.8K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 30 | $210 | $6.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 30 | $170 | $5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 60 | $70 | $3.8K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 70 | $50 | $3.7K |